2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Solid Tumor
1
Interventions
pembrolizumab
1270
Specimen Handling
921
Magnetic Resonance Spectroscopy
832
Carboplatin
829
Cyclophosphamide
802
Cisplatin
726
Nivolumab
682
Paclitaxel
639
Radiotherapy
613
Gemcitabine
578
Biopsy
556
Bevacizumab
477
Dexamethasone
445
fludarabine
405
Docetaxel
382
venetoclax
372
Oxaliplatin
365
Capecitabine
360
Fluorouracil
358
atezolizumab
345
durvalumab
338
Rituximab
336
Drug Therapy
330
Doxorubicin
319
Radiosurgery
316
Blood Specimen Collection
313
Pemetrexed
308
Standard of Care
306
Ipilimumab
305
Radiation
285
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Off-Label Use
×
1 year
×
Clear all
NCT06956248
2026-05-13
IMPACT-INSPIRE
National Cancer Centre, Singapore
Recruiting
50 enrolled